Drug
Hr070803 Oxaliplatin 5fluorouracil Calcium Folinate
Hr070803 Oxaliplatin 5fluorouracil Calcium Folinate: highest development phase Phase 3, developed by Jiangsu Hengrui Medicine. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate NCT05751850 | Phase 3 | First-line Treatment of Advanced Pancreatic Cancer |
Latest
No recent events.
Follow Hr070803 Oxaliplatin 5fluorouracil Calcium Folinate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.